Sangamo Therapeutics Inc. News
Mad Money Recap With Jim Cramer: Science Is Winning
If the vaccine rollout works like we hope it will, Jim Cramer says, the winning stocks of the post-COVID world include aerospace, retail, restaurants, autos and financials.
Biogen Reports Better-Than-Expected Earnings - Stock Lower
Biogen reports better-than-expected first-quarter earnings and says the pandemic brings "unanticipated and potentially unquantifiable risks to our business" near term.
Fight the Fear: Cramer's 'Mad Money' Recap (Thursday 3/5/20)
Jim Cramer says fear is widespread, and it's impossible to call the bottom. But he recalls the wisdom of Warren Buffett.
Sangamo Shares Soar as Hemophilia Drug Shows Promise
Sangamo's stock price is surging after a pair of patients reported no bleeding events for as long as 24 weeks following treatment following investigational SB-525 gene therapy for severe hemophilia A.
Sangamo Stock Soars on Positive Hemophilia Treatment Trial
The stock surges on 'encouraging' results from a genome-therapy trial for the treatment of a severe type of hemophilia.
Fed Inflation Gauge Eases Again In May, But Inflation Pressures Clip Consumer Spending
While overall inflation pressures are easing modestly, the impact of the fastest inflation in four decades is taking its toll on spending, BEA data indicated Thursday.
Pfizer Stock Jumps On $3.2 Billion U.S. Covid Vaccine Sale, FDA Paxlovid Approval Filing
“As the Covid pandemic continues to evolve and be highly unpredictable, we must remain vigilant in protecting those who are at greatest risk of getting very sick from Covid," said CEO Albert Bourla.
Walgreens Stock Slides After Q3 Profit Beat, $683 Million Florida Opioid Charge
"WBA delivered strong execution across operating segments and against very robust growth last year," said CEO Rosalind Brewer.
Micron Earnings Preview: Will Critical Support Hold?
Micron is set to report earnings on Thursday after the close, but the stock sits on critical support. Will it hold or will it fold?